Literature DB >> 28687608

Thioredoxin reductase from Toxoplasma gondii: an essential virulence effector with antioxidant function.

Junxin Xue1,2,3, Wei Jiang1, Yongjun Chen1, Fengju Gong2, Minyan Wang1, Peng Zeng2, Can Xia2, Quan Wang4, Kehe Huang5.   

Abstract

Thioredoxin reductase (TR) can help pathogens resist oxidative-burst injury from host immune cells by maintaining a thioredoxin-reduction state during NADPH consumption. TR is a necessary virulence factor that enables the persistent infection of some parasites. We performed bioinformatics analyses and biochemical assays to characterize the activity, subcellular localization, and genetic ablation of Toxoplasma gondii TR (TgTR), to shed light on its biologic function. We expressed the TgTR protein with an Escherichia coli expression system and analyzed its enzyme activity, reporting a Km for the recombinant TgTR of 11.47-15.57 μM, using NADPH as a substrate, and 130.48-151.09 μM with dithio-bis-nitrobenzoic acid as a substrate. The TgTR sequence shared homology with that of TR, but lacked a selenocysteine residue in the C-terminal region and was thought to contain 2 flavin adenine dinucleotide (FAD) domains and 1 NADPH domain. In addition, immunoelectron microscopy results showed that TgTR was widely dispersed in the cytoplasm, and we observed that parasite antioxidant capacity, invasion efficiency, and proliferation were decreased in TR-knockout (TR-KO) strains in vitro, although this strain still stimulated the release of reactive oxygen species release in mouse macrophages while being more sensitive to H2O2 toxicity in vitro Furthermore, our in vivo results revealed that the survival time of mice infected with the TR-KO strain was significantly prolonged relative to that of mice infected with the wild-type strain. These results suggest that TgTR plays an important role in resistance to oxidative damage and can be considered a virulence factor associated with T. gondii infection.-Xue, J., Jiang, W., Chen, Y., Gong, F., Wang, M., Zeng, P., Xia, C., Wang, Q., Huang, K. Thioredoxin reductase from Toxoplasma gondii: an essential virulence effector with antioxidant function. © FASEB.

Entities:  

Keywords:  enzyme activity; gene knockout; immune evasion; protein expression

Mesh:

Substances:

Year:  2017        PMID: 28687608     DOI: 10.1096/fj.201700008R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  11 in total

1.  Repurposing auranofin for treatment of Experimental Cerebral Toxoplasmosis.

Authors:  Iman Fathy Abou-El-Naga; Nermine Mogahed Fawzy Hussein Mogahed
Journal:  Acta Parasitol       Date:  2021-02-08       Impact factor: 1.440

Review 2.  Host cell proteins modulated upon Toxoplasma infection identified using proteomic approaches: a molecular rationale.

Authors:  Sajad Rashidi; Carmen Vieira; Reza Mansouri; Mohammad Ali-Hassanzadeh; Esmaeel Ghani; Mohammadreza Karimazar; Paul Nguewa; Raúl Manzano-Román
Journal:  Parasitol Res       Date:  2022-05-13       Impact factor: 2.289

3.  Global profiling of protein lysine malonylation in Toxoplasma gondii strains of different virulence and genetic backgrounds.

Authors:  Lan-Bi Nie; Qin-Li Liang; Meng Wang; Rui Du; Meng-Yuan Zhang; Hany M Elsheikha; Xing-Quan Zhu
Journal:  PLoS Negl Trop Dis       Date:  2022-05-16

4.  The Selenium Yeast vs Selenium Methionine on Cell Viability, Selenoprotein Profile and Redox Status via JNK/ P38 Pathway in Porcine Mammary Epithelial Cells.

Authors:  Caichi Wu; Chang Cui; Xiaoyu Zheng; Jun Wang; Ziwei Ma; Pengwei Zhu; Gang Lin; Shihai Zhang; Wutai Guan; Fang Chen
Journal:  Front Vet Sci       Date:  2022-04-01

Review 5.  Sixty Years (1957-2017) of Research on Toxoplasmosis in China-An Overview.

Authors:  Ming Pan; Congcong Lyu; Junlong Zhao; Bang Shen
Journal:  Front Microbiol       Date:  2017-09-25       Impact factor: 5.640

6.  Auranofin Resistance in Toxoplasma gondii Decreases the Accumulation of Reactive Oxygen Species but Does Not Target Parasite Thioredoxin Reductase.

Authors:  Christopher I Ma; James A Tirtorahardjo; Sharon Jan; Sakura S Schweizer; Shawn A C Rosario; Yanmiao Du; Jerry J Zhang; Naomi S Morrissette; Rosa M Andrade
Journal:  Front Cell Infect Microbiol       Date:  2021-03-19       Impact factor: 5.293

Review 7.  Modulation of autophagy as a therapeutic strategy for Toxoplasma gondii infection.

Authors:  Ao Cheng; Huanan Zhang; Baike Chen; Shengyao Zheng; Hongyi Wang; Yijia Shi; Siyao You; Ming Li; Liping Jiang
Journal:  Front Cell Infect Microbiol       Date:  2022-08-24       Impact factor: 6.073

Review 8.  Oxidative Stress as a Possible Target in the Treatment of Toxoplasmosis: Perspectives and Ambiguities.

Authors:  Karolina Szewczyk-Golec; Marta Pawłowska; Roland Wesołowski; Marcin Wróblewski; Celestyna Mila-Kierzenkowska
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

Review 9.  Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System.

Authors:  Holly C May; Jieh-Juen Yu; M N Guentzel; James P Chambers; Andrew P Cap; Bernard P Arulanandam
Journal:  Front Microbiol       Date:  2018-03-05       Impact factor: 5.640

10.  Involvement of Urm1, a Ubiquitin-Like Protein, in the Regulation of Oxidative Stress Response of Toxoplasma gondii.

Authors:  Qianqian Tan; Jinwen Wang; Junpeng Chen; Xiaomei Liu; Xiao Chen; Qianqian Xiao; Jinxuan Li; Hongmei Li; Xiaomin Zhao; Xiao Zhang
Journal:  Microbiol Spectr       Date:  2022-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.